Evidence map›Paper›PMID 29233751›Full record

ArticleBrain, behavior, and immunity2018

Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum.

Luciana R Frick, Maximiliano Rapanelli, Kantiya Jindachomthong, Paul Grant, James F Leckman, Susan Swedo, Kyle Williams, Christopher Pittenger

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01281969 (A Placebo-Controlled Trial of Intravenous Immunoglobulin), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01281969 phase3completednot on this map

A Placebo-Controlled Trial of Intravenous Immunoglobulin (IVIG) for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections)

TypeinterventionalSponsorNational Institute of Mental Health (NIMH)Ran2011 to 2018Enrolled48ConditionsObsessive-Compulsive Disorder, Children, Anxiety Disorder, Autoimmune DiseaseArmsGamunex Intravenous Immunoglobulin, Placebo
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Neuropsychiatric Symptoms and Tick-Borne Diseases.Current topics in behavioral neurosciences · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Luciana R FrickDepartment of Psychiatry, Yale University, United States.
Maximiliano RapanelliDepartment of Psychiatry, Yale University, United States.
Kantiya JindachomthongDepartment of Psychiatry, Yale University, United States.
Paul GrantPediatrics and Developmental Neuroscience Branch, National Institute of Mental Health, United States.
James F LeckmanDepartment of Psychology, Yale University, United States; Child Study Center, Yale University, United States.
Susan SwedoPediatrics and Developmental Neuroscience Branch, National Institute of Mental Health, United States.
Kyle WilliamsDepartment of Psychiatry, Yale University, United States; Child Study Center, Yale University, United States; Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, United States. Electronic address: KWILLIAMS42@partners.org.
Christopher PittengerDepartment of Psychiatry, Yale University, United States; Department of Psychology, Yale University, United States; Child Study Center, Yale University, United States; Interdepartmental Neuroscience Program, Yale University, United States. Electronic address: christopher.pittenger@yale.edu.
Yale University · USNational Institute of Mental Health · USHarvard University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Evaluation and Treatment of Obsessive Compulsive and Related DisordersZIAMH002666 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SWEDO, SUSAN · 2009 to 2019
$7.6M
Institutional Career DevelopmentKL2TR001413 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2015 to 2024
$4.2M
Research Training for Medical Students & Physician-Scientists in Child PsychiatryR25MH077823 · NIMH · YALE UNIVERSITY · PI ANDRES S MARTIN · 2006 to 2026
$4.0M
Pathophysiologically Realistic Mouse Models of Neuropsychiatric Disease: TouretteR01MH091861 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2010 to 2014
$2.0M
EVALUATION AND TREATMENT OF OBSESSIVE COMPULSIVE AND RELATED DISORDERSZ01MH002666 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SWEDO, SUSAN E. · 1993 to 2008
$820k
Intramural NIH HHS Z01 MH002666NCATS NIH HHS KL2 TR001413NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH091861NIMH NIH HHS R25 MH077823
6 · The paper itself

Abstract

Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus, or PANDAS, is a syndrome of acute childhood onset of obsessive-compulsive disorder and other neuropsychiatric symptoms in the aftermath of an infection with Group A beta-hemolytic Streptococcus (GABHS). Its pathophysiology remains unclear. PANDAS has been proposed to result from cross-reactivity of antibodies raised against GABHS with brain antigens, but the targets of these antibodies are unclear and may be heterogeneous. We developed an in vivo assay in mice to characterize the cellular targets of antibodies in serum from individuals with PANDAS. We focus on striatal interneurons, which have been implicated in the pathogenesis of tic disorders. Sera from children with well-characterized PANDAS (n = 5) from a previously described clinical trial (NCT01281969), and matched controls, were infused into the striatum of mice; antibody binding to interneurons was characterized using immunofluorescence and confocal microscopy. Antibodies from children with PANDAS bound to ∼80% of cholinergic interneurons, significantly higher than the <50% binding seen with matched healthy controls. There was no elevated binding to two different populations of GABAergic interneurons (PV and nNOS-positive), confirming the specificity of this phenomenon. Elevated binding to cholinergic interneurons resolved in parallel with symptom improvement after treatment with intravenous immunoglobulin. Antibody-mediated dysregulation of striatal cholinergic interneurons may be a locus of pathology in PANDAS. Future clarification of the functional consequences of this specific binding may identify new opportunities for intervention in children with this condition.

Indexed as

AnimalsAntibodiesAutoimmune DiseasesChildChild, PreschoolCholinergic NeuronsCorpus StriatumFemaleHumansInterneuronsMaleMiceObsessive-Compulsive DisorderStreptococcal InfectionsAntibodiesAnimal modelAntibodyAutoimmunityInterneuronsObsessive-compulsive disorderPANDASTics

Identifiers

PMID29233751
PMCPMC5857467
OpenAlexW2771566870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.